Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...
Vepdegestrant is a novel proteolysis targeting chimera protein degrader designed to target and degrade the estrogen receptor.
Cancer research saved my daughter’s life, and despite setbacks, we must support these efforts to ensure more lives are saved ...
The New Times on MSN2d
Rwanda to host Africa’s first eye and cancer drug facilityRwanda is set to become home to Africa’s first manufacturing plant for eye care products and monoclonal antibodies targeting cancer, with completion expected by 2026, according to Dr. Menghis Bairu, ...
DEVASTATED Nadia Sawalha fought back tears in an emotional video as she shared some heartbreaking news. Loose Women star ...
Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...
Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...
Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall mortality rates from the ...
Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 ...
Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these ...
Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback